As cancer clinical trials go global, balancing operational efficiency with regulatory relevance becomes more challenging. Lola Fashoyin-Aje will lead an #AACR26 panel to explore policies to strengthen the clinical trial ecosystem.

https://
brnw.ch/21x1JvD #AACRSciencePolicy